Kathrin Koch

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Cerebrospinal Fluid

Patient Reported

Regulatory T Cells

Induced Apoptosis

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Claudia Janoschka, Maren Lindner, Nils Koppers, Laura Starost, Marie Liebmann, Melanie Eschborn, Tilman Schneider-Hohendorf, Farina Windener, David Schafflick, Ann-Katrin Fleck, Kathrin Koch, Marie Deffner, Anna-Sophie Schwarze, Andreas Schulte-Mecklenbeck, Imke Metz, Sven G Meuth, Catharina C Gross, Gerd Meyer Zu Hörste, Nicholas Schwab, Tanja Kuhlmann, Heinz Wiendl, Monika Stoll, Luisa Klotz
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound. Proceedings of the National Academy of Sciences of the United States of America 120 (1) (2022)
Claudia Janoschka, Maren Lindner, Nils Koppers, Laura Starost, Marie Liebmann, Melanie Eschborn, Tilman Schneider-Hohendorf, Farina Windener, David Schafflick, Ann-Katrin Fleck, Kathrin Koch, Marie Deffner, Anna-Sophie Schwarze, Andreas Schulte-Mecklenbeck, Imke Metz, Sven G Meuth, Catharina C Gross, Gerd Meyer Zu Hörste, Nicholas Schwab, Tanja Kuhlmann, Heinz Wiendl, Monika Stoll, Luisa Klotz
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound. Proceedings of the National Academy of Sciences of the United States of America 120 (1) (2022)
Claudia Janoschka, Maren Lindner, Nils Koppers, Laura Starost, Marie Liebmann, Melanie Eschborn, Tilman Schneider-Hohendorf, Farina Windener, David Schafflick, Ann-Katrin Fleck, Kathrin Koch, Marie Deffner, Anna-Sophie Schwarze, Andreas Schulte-Mecklenbeck, Imke Metz, Sven G Meuth, Catharina C Gross, Gerd Meyer Zu Hörste, Nicholas Schwab, Tanja Kuhlmann, Heinz Wiendl, Monika Stoll, Luisa Klotz
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound. Proceedings of the National Academy of Sciences of the United States of America 120 (1) (2022)
Claudia Janoschka, Maren Lindner, Nils Koppers, Laura Starost, Marie Liebmann, Melanie Eschborn, Tilman Schneider-Hohendorf, Farina Windener, David Schafflick, Ann-Katrin Fleck, Kathrin Koch, Marie Deffner, Anna-Sophie Schwarze, Andreas Schulte-Mecklenbeck, Imke Metz, Sven G Meuth, Catharina C Gross, Gerd Meyer Zu Hörste, Nicholas Schwab, Tanja Kuhlmann, Heinz Wiendl, Monika Stoll, Luisa Klotz
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound. Proceedings of the National Academy of Sciences of the United States of America 120 (1) (2022)
Claudia Janoschka, Maren Lindner, Nils Koppers, Laura Starost, Marie Liebmann, Melanie Eschborn, Tilman Schneider-Hohendorf, Farina Windener, David Schafflick, Ann-Katrin Fleck, Kathrin Koch, Marie Deffner, Anna-Sophie Schwarze, Andreas Schulte-Mecklenbeck, Imke Metz, Sven G Meuth, Catharina C Gross, Gerd Meyer Zu Hörste, Nicholas Schwab, Tanja Kuhlmann, Heinz Wiendl, Monika Stoll, Luisa Klotz
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound. Proceedings of the National Academy of Sciences of the United States of America 120 (1) (2022)